Last Wednesday President Vladimir Putin announced a $1B initiative to fund nanotech research and aid companies with investments in the science. The money would also help transform the Kurchatov nuclear institute into the hub for Russian nanotech research. The initiative stems from Russia's massive oil and gas export and is intended, according to Minister Sergei Ivanov, to diversify an economy now heavily dependent on raw materials. The money is in addition to the approximately $5.8B that Russia has already devoted to nanotech research.
Ivanov, who will head the budgeting of the nanotechnology initiative, predicted that 90% of the money will go to fund civilian applications, with the rest going toward the military. Putin added that “No doubt, nanotechnologies will become a key industry for the creation of ultra-modern and ultra-effective offensive and defensive weapons, as well as means of communications.”
This last quote certainly compels concern, especially given the strained relations between the United States and Russia as of late. With all the attention being given to the health concerns of domestic nanotechnology manufacturing, it seems that the threat of nanotech-enabled weaponry has been overshadowed.
Below are some links to articles regarding nanoweapons:
CRNano.com
Janes.com
Newsmax.com
4.20.2007
TECHNOLOGY: Nanorust
Water purification has become a major issue in third world countries, where thousands of people die each year from arsenic contamination in their drinking water wells. A lab at Ri
ce University recently published an article in Science magazine describing small crystals containing Fe3O4 rust particles dubbed "nanorust", which may prove to be an answer to low-cost and effective water purification in these countries. These nanorust crystals serve as another example of how the unique properties of nanoscale materials can be applied in today's industries.
A general principle of magnetics states that as particles get smaller, the amount of magnetic force required to move the particles increases. This relationship is due to the fact that magnetic power is proportional to the volume of the material acted upon, so when particles get too small their magnetic power potential falls below the threshold required to overcome initial inertia. A lab at Rice led by Dr. Vicki Colvin sought to test this principle on the nanoscale and found that, after reaching a critical threshold of approximately 50 nm, it becomes easier to manipulate the materials. This, they propose, is due to the fact that at this miniscule size, the particles exert forces on each other in a cooperative manner that allows for magnetic separations with even weak handheld magnets.
After proving this concept of nanoscale separation, Dr. Colvin's lab tested the potential of this method to remove arsenic from drinking water. Taking advantage of the tendency of rust to bind arsenic, the lab found that adding nanorust to water and applying a magnetic field effectively removed the arsenic and purified the water enough to meet EPA standards.
The benefits of this method of magnetic separation over traditional separation methods such as centrifugation and filtration are a few fold. The process is not only more selective and efficient than its counterparts, but it may also turn out to be a much cheaper method. While Dr. Covlin admits that the process is too expensive to currently use in water filtration, they claim to be working on methods that will eventually produce nanorust at a very low cost and scalable level.
(FIGURE from TechnologyReview.com)
ce University recently published an article in Science magazine describing small crystals containing Fe3O4 rust particles dubbed "nanorust", which may prove to be an answer to low-cost and effective water purification in these countries. These nanorust crystals serve as another example of how the unique properties of nanoscale materials can be applied in today's industries.A general principle of magnetics states that as particles get smaller, the amount of magnetic force required to move the particles increases. This relationship is due to the fact that magnetic power is proportional to the volume of the material acted upon, so when particles get too small their magnetic power potential falls below the threshold required to overcome initial inertia. A lab at Rice led by Dr. Vicki Colvin sought to test this principle on the nanoscale and found that, after reaching a critical threshold of approximately 50 nm, it becomes easier to manipulate the materials. This, they propose, is due to the fact that at this miniscule size, the particles exert forces on each other in a cooperative manner that allows for magnetic separations with even weak handheld magnets.
After proving this concept of nanoscale separation, Dr. Colvin's lab tested the potential of this method to remove arsenic from drinking water. Taking advantage of the tendency of rust to bind arsenic, the lab found that adding nanorust to water and applying a magnetic field effectively removed the arsenic and purified the water enough to meet EPA standards.
The benefits of this method of magnetic separation over traditional separation methods such as centrifugation and filtration are a few fold. The process is not only more selective and efficient than its counterparts, but it may also turn out to be a much cheaper method. While Dr. Covlin admits that the process is too expensive to currently use in water filtration, they claim to be working on methods that will eventually produce nanorust at a very low cost and scalable level.
(FIGURE from TechnologyReview.com)
4.16.2007
COMPANY: Nanophase
Overview
Nanophase was founded in Romeoville, IL in 1989 and is currently publically traded with a market cap of $130M. Nanophase is one of the
first companies founded in the nanomaterials field and specializes in manufacturing metal-oxide powders for use in a wide variety of applications, including personal care, semiconductors, optics, and environmental catalysts. Nanophase's business model relies on partnerships with businesses in target markets. Nanophase's current exclusive partnerships with BASF, Rohm, and Haas Electronic Materials brought in $9M in revenue in 2006, and is reporting first quarter revenues of $2.9M in 2007, representing a year-over-year growth of 45% - the highest in the field.
Nanophase.com
Technology
Nanophase produces nanocrystalline powders containing nanoscale grains with properties capable of enhancing the performance of other materials. Nanophase has produced powders designed to enhance the chemical, mechanical, electrical and optical behavior of materials. Nanophase has combined methods of Physical Vapor Synthesis and Nanoarc Synthesis with a patented polymer coating to manufacture a variety of nanocoatings, including some that are compatible with fluids - a feat unmatched by current competitors.
Applications
Antimicrobial- Powders have been developed with antimicrobial properties to aid in the preservation of certain materials including wood, plastics, textiles, and materials subjected to harsh conditions.
Catalysts- Nanomaterials can be used as catalytic converters for more efficient emissions in fuels or for the creation of fuel cells.
Performance Coatings- Powders can be used as coatings to dimish the effects of UV rays, static charge, and general abrasion on materials.
Personal Care- Nanomaterials can be used as sunscreens, deodorants, dental coatings, and antibacterial coatings in personal care products.
Polishing- Nanophase's uniquely blended polishes can be used for high-quality semiconductor or glass polishing.
Products
For a list of Nanophase's products, see their catalog.
Collaborations
BASF- Nanophase partners with BASF for sunscreen and personal care applications.
Rohm & Haas- This partnership is largely for semiconductor applications.
BYK Chemie- For coatings and ink applications.
Alfa Aesar- For research sample distribution.
(FIGURE from NSTI.org)
Nanophase was founded in Romeoville, IL in 1989 and is currently publically traded with a market cap of $130M. Nanophase is one of the
first companies founded in the nanomaterials field and specializes in manufacturing metal-oxide powders for use in a wide variety of applications, including personal care, semiconductors, optics, and environmental catalysts. Nanophase's business model relies on partnerships with businesses in target markets. Nanophase's current exclusive partnerships with BASF, Rohm, and Haas Electronic Materials brought in $9M in revenue in 2006, and is reporting first quarter revenues of $2.9M in 2007, representing a year-over-year growth of 45% - the highest in the field.Nanophase.com
Technology
Nanophase produces nanocrystalline powders containing nanoscale grains with properties capable of enhancing the performance of other materials. Nanophase has produced powders designed to enhance the chemical, mechanical, electrical and optical behavior of materials. Nanophase has combined methods of Physical Vapor Synthesis and Nanoarc Synthesis with a patented polymer coating to manufacture a variety of nanocoatings, including some that are compatible with fluids - a feat unmatched by current competitors.
Applications
Antimicrobial- Powders have been developed with antimicrobial properties to aid in the preservation of certain materials including wood, plastics, textiles, and materials subjected to harsh conditions.
Catalysts- Nanomaterials can be used as catalytic converters for more efficient emissions in fuels or for the creation of fuel cells.
Performance Coatings- Powders can be used as coatings to dimish the effects of UV rays, static charge, and general abrasion on materials.
Personal Care- Nanomaterials can be used as sunscreens, deodorants, dental coatings, and antibacterial coatings in personal care products.
Polishing- Nanophase's uniquely blended polishes can be used for high-quality semiconductor or glass polishing.
Products
For a list of Nanophase's products, see their catalog.
Collaborations
BASF- Nanophase partners with BASF for sunscreen and personal care applications.
Rohm & Haas- This partnership is largely for semiconductor applications.
BYK Chemie- For coatings and ink applications.
Alfa Aesar- For research sample distribution.
(FIGURE from NSTI.org)
4.12.2007
TECHNOLOGY: Nanogenerator
Much of the buzz surrounding nanotech has been centered around the prospect of nanoscale devices. Nanotech pundits theorize that these devices will serve as "smart molecules", 
building nanostructures and treating diseases on their own power. Before these nanodevices can be used on a mass scale, however, a nanoscale power source must be developed. There are two major requirements that this power source must fulfill. First, it must be small enough that it maintains the nanoscale size advantage of the device after it is coupled with that device. Second, these devices must be able to generate power from their immediate surroundings.
Scientists from the Georgia Institute of Technology recently published an article in Science detailing the creation of a nanoscale generator (see figure 1) capable of generating power from environmental phenomena such as ultrasonic waves, mechanical vibrations, and even blood flow. These generators consist of zinc-oxide nanowires (nanowires are nanotubes made out of elements other than carbon) which create charges based on their movements in relation to a jagged silicon electrode plate (see figure 2).
The nanowires are moved by environmental forces such as waves or vibrations, which cause charge to be transfered from the wires to the electrode. This transfer of charge can create a current on the level of nano-Amps which, with further optimization, could lead to up to 4 watts of power delivered per square centimeter.
These nanogenerators are non-toxic and represent a large step in the development of nanoscale "smart molecules". Imagine drugs that live in your body and work to not only cure ailments, but maintain the body and prevent potential ailments as well. These generators could provide the power necessary for such long term pharmaceutical action.
(FIGURE 1 from HipTechBlog.com, FIGURE 2 from Science article)
building nanostructures and treating diseases on their own power. Before these nanodevices can be used on a mass scale, however, a nanoscale power source must be developed. There are two major requirements that this power source must fulfill. First, it must be small enough that it maintains the nanoscale size advantage of the device after it is coupled with that device. Second, these devices must be able to generate power from their immediate surroundings.Scientists from the Georgia Institute of Technology recently published an article in Science detailing the creation of a nanoscale generator (see figure 1) capable of generating power from environmental phenomena such as ultrasonic waves, mechanical vibrations, and even blood flow. These generators consist of zinc-oxide nanowires (nanowires are nanotubes made out of elements other than carbon) which create charges based on their movements in relation to a jagged silicon electrode plate (see figure 2).
The nanowires are moved by environmental forces such as waves or vibrations, which cause charge to be transfered from the wires to the electrode. This transfer of charge can create a current on the level of nano-Amps which, with further optimization, could lead to up to 4 watts of power delivered per square centimeter.
These nanogenerators are non-toxic and represent a large step in the development of nanoscale "smart molecules". Imagine drugs that live in your body and work to not only cure ailments, but maintain the body and prevent potential ailments as well. These generators could provide the power necessary for such long term pharmaceutical action.
(FIGURE 1 from HipTechBlog.com, FIGURE 2 from Science article)
4.04.2007
COMPANY: Arrowhead Research
Overview
Insert Therapeutics- Couples its patented delivery technology, Cytosert, with drugs for improved drug solubility, stability, circulation, and targeting for enhanced safety and efficacy. The cytosert linkage lengthens the drug combination and, through the enhaced permeability and retention (EPR) effect of tumor cells, prevents loss of drug by normal vessel leakage while enhancing drug accumulation in targeted tumor cells.
Calando Pharmaceuticals- Utilizes the phenomenon of RNA interference (RNAi) to “silence” the expression of disease causing genes. While the RNAi technology is rather widely used, Calando uses self-assembling nanoparticles to prime the drug for intravenous injection. Preclinical studies on this polymer-RNAi combination have been promising.
Unidym- Uses carbon nanomaterials (buckytubes and buckyballs) in the development of next-generation electronics. The technology is based on networks of carbon nanotubes, leading to high electrical conductivity, mechanical flexibility, transparency, and environmental resistance. Initial products include transparent and electrically conductive films that offer competitive alternatives to indium tin oxide (ITO) in applications such as flat panel displays, touch screens, and solar cells.
News
1.10.2006- Arrowhead is selected for inclusion in the Powershares Lux Nanotech Portfolio, which is intended to track a group of leading companies involved in developing and manufacturing nanotechnology.
Collaborations
2.22.2005- Arrowhead launches Calando Pharmaceuticals as a majority-owned subsidiary to develop new technology taking advantage of RNAi technology
Arrowhead Research Corporation is a publicly traded company based in Pasadena, CA with a market cap of around $160M. Arrowhead focuses on developing nanotechnology with sponsored research grants to top institutions and through research and development within its subsidiary co
mpanies, Aonex Technologies, Insert Therapeutics, Calando Pharmaceuticals, and Unidym. Arrowhead's business plan involves commercializing nanotechnology products owned by its subsidiaries, funding nanotech R&D in exchange for licensing rights, and acquiring IP for nanotechnologies.
mpanies, Aonex Technologies, Insert Therapeutics, Calando Pharmaceuticals, and Unidym. Arrowhead's business plan involves commercializing nanotechnology products owned by its subsidiaries, funding nanotech R&D in exchange for licensing rights, and acquiring IP for nanotechnologies.Subsidiaries
Aonex Technologies- Specializes in nano-enables semiconductor fabrication to reduce costs, improve performance, and integrate multiple functions into a single device. The technology under Aonex has many applications in electronics, but the major focus is currently on next-generation solar cells.
Insert Therapeutics- Couples its patented delivery technology, Cytosert, with drugs for improved drug solubility, stability, circulation, and targeting for enhanced safety and efficacy. The cytosert linkage lengthens the drug combination and, through the enhaced permeability and retention (EPR) effect of tumor cells, prevents loss of drug by normal vessel leakage while enhancing drug accumulation in targeted tumor cells.
Calando Pharmaceuticals- Utilizes the phenomenon of RNA interference (RNAi) to “silence” the expression of disease causing genes. While the RNAi technology is rather widely used, Calando uses self-assembling nanoparticles to prime the drug for intravenous injection. Preclinical studies on this polymer-RNAi combination have been promising.
Unidym- Uses carbon nanomaterials (buckytubes and buckyballs) in the development of next-generation electronics. The technology is based on networks of carbon nanotubes, leading to high electrical conductivity, mechanical flexibility, transparency, and environmental resistance. Initial products include transparent and electrically conductive films that offer competitive alternatives to indium tin oxide (ITO) in applications such as flat panel displays, touch screens, and solar cells.
News
1.25.2006- Arrowhead receives $19.6M in institutional investments from York Capital Management and Knott Partners in exchange for stock.
1.10.2006- Arrowhead is selected for inclusion in the Powershares Lux Nanotech Portfolio, which is intended to track a group of leading companies involved in developing and manufacturing nanotechnology.
Collaborations
6.14.2006- Arrowhead acquires nanoelectronics company Unidym for $7M
2.22.2005- Arrowhead launches Calando Pharmaceuticals as a majority-owned subsidiary to develop new technology taking advantage of RNAi technology
4.02.2007
TECHNOLOGY: Buckyballs
Buckminsterfullerenes, or buckyballs as they are more commonly known, are the spherical equivalent to carbon nanotubes. The carbon lattice in buckyballs consists of pentagonal ca
rbon chains surrounded by hexagonal chains in a pattern much like that of a soccer ball (see figure). This pattern allows the carbon lattice to bend in a way that is most stable in a hollow spherical form.
rbon chains surrounded by hexagonal chains in a pattern much like that of a soccer ball (see figure). This pattern allows the carbon lattice to bend in a way that is most stable in a hollow spherical form.The most immediately apparent contributions that these buckyballs may make lie in the field of drug delivery and transport within the body. Currently, liposomes are used to transport drugs through the body for a slower acting and longer lasting effect with better localization to target areas. These liposomes can be introduced through many different methods, including inhalation. However, these liposomes are often targeted by killer cells in our immune system and tend to be cleared from lung tissue very quickly, decreasing the effectiveness of the drug.
Buckyballs have recently been proposed as a potential replacement for liposomes in this type of drug delivery. The superior biological stability of buckyballs allows them to be retained in the lung much longer than liposomes for better drug delivery. Moreover, the simple lattice structure of these buckyballs make it easy to attach multiple drugs to the system, allowing for drug cocktails designed for more complicated action on target sites. A recent article published in the JACS demonstrated that when coupled with cancer drug, Paclitaxel, these buckyballs show an ability to remain in the lung longer than traditional liposomes.
A lab in Cornell is currently researching a method of creating buckyballs out of DNA molecules, and several other labs are working on further potential uses for these balls. Further applications include uses as molecular ball bearings, optical devices, and semiconductors.
Buckyballs have recently been proposed as a potential replacement for liposomes in this type of drug delivery. The superior biological stability of buckyballs allows them to be retained in the lung much longer than liposomes for better drug delivery. Moreover, the simple lattice structure of these buckyballs make it easy to attach multiple drugs to the system, allowing for drug cocktails designed for more complicated action on target sites. A recent article published in the JACS demonstrated that when coupled with cancer drug, Paclitaxel, these buckyballs show an ability to remain in the lung longer than traditional liposomes.
A lab in Cornell is currently researching a method of creating buckyballs out of DNA molecules, and several other labs are working on further potential uses for these balls. Further applications include uses as molecular ball bearings, optical devices, and semiconductors.
(FIGURE from http://www.osti.gov/accomplishments/images/buckyball.gif)
Subscribe to:
Posts (Atom)
